生物過程分析儀市場 - 按產品、分析類型、應用、最終用途 - 全球預測

2024 年至2032 年間，生物製程分析儀市場規模的複合年成長率將達到15.2%。對生物製程分析儀的需求，以監測和最佳化生物製藥生產過程。根據世界衛生組織的數據，2022 年，約有 2,000 萬個新診斷癌症病例，死亡人數達 970 萬人。在生物技術和個人化醫療進步的推動下，生物製藥產業在全球範圍內不斷擴張，對先進分析工具的需求日益成長，以確保產品品質、一致性和法規遵循。

生物製程分析儀不斷取得的技術進步，包括自動化、小型化和先進感測器技術的整合，提高了其效率、準確性和可靠性，推動了其在生物製藥生產設施中的採用。這些先進的分析儀能夠即時監測關鍵製程參數，例如細胞活力、代謝物濃度和產品滴度，促進製程最佳化並加速生物製藥產品的上市時間。

生物製程分析儀產業分為產品、分析類型、應用、最終用途和地區

根據產品，到2032 年，儀器領域的市場價值預計將實現15.4% 的複合年成長率。分析儀器。分光光度計、色譜系統和質譜儀等儀器可以即時分析關鍵製程參數，以確保產品品質、一致性和法規遵循。

抗生素應用領域的生物過程分析儀市場預計在 2024 年至 2032 年期間將以 15.4% 的複合年成長率產生可觀的收入。傳染病和抗生素抗藥性病原體的日益流行正在推動對新型抗生素和抗菌劑的需求，因此需要高效的生物程序來生產它們。為此，生物製程分析儀有助於最佳化發酵和純化過程，同時確保抗生素生產的品質、產量和一致性。

到2032 年，亞太地區生物製程分析儀市場規模將實現15.8% 的成長率。流程中的製程最佳化和品質控制。生物製程分析儀的快速技術進步，例如自動化、小型化和即時監控功能，以提高其效率和準確性，將進一步推動區域市場的成長。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 對生物製藥產品的需求不斷成長
    • 生物技術和生物加工的進步
    • 對生物相似藥的需求不斷增加
    • 政府措施和資金不斷增加
  • 產業陷阱與挑戰
    • 儀器成本高
    • 複雜性和技術專長
• 成長潛力分析
• 監管環境
• 技術景觀
• 波特的分析
• PESTEL分析

第 4 章：競爭格局

• 介紹
• 公司市佔率分析
• 競爭定位矩陣
• 戰略展望矩陣

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

• 主要趨勢
• 儀器
• 耗材及配件

第 6 章：市場估計與預測：按分析類型，2021 - 2032 年

• 主要趨勢
• 底物分析
• 代謝物分析
• 含量檢測

第 7 章：市場估計與預測：按應用分類，2021 - 2032

• 主要趨勢
• 抗生素
• 重組蛋白
• 生物相似藥
• 其他應用

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

• 主要趨勢
• 生物製藥公司
• CRO 和 CMO
• 研究與學術機構
• 其他最終用戶

第 9 章：市場估計與預測：按地區，2021 - 2032

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 歐洲其他地區
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
• 中東和非洲
  • 沙烏地阿拉伯
  • 南非
  • 阿拉伯聯合大公國
  • 中東和非洲其他地區

第 10 章：公司簡介

• Agilent Technologies, Inc.
• Algenax
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Groton Biosystems LLC
• Kaiser Optical Systems, Inc.
• Nova Biomedical
• Randox Laboratories Ltd.
• Sartorius AG
• SYSBIOTECH GmbH
• Thermo Fisher Scientific Inc.
• YSI Inc.

Bioprocess analyzers market size will record 15.2% CAGR between 2024 and 2032. The increasing adoption of biopharmaceuticals for the treatment of various diseases, including cancer, autoimmune disorders, and infectious diseases is fueling the demand for bioprocess analyzers to monitor and optimize biopharmaceutical production processes. As per WHO, in 2022, approximately 20 million new cancer diagnoses were recorded, with fatalities reaching 9.7 million. As the biopharmaceutical industry continues to expand globally, driven by advancements in biotechnology and personalized medicine, there is a growing need for advanced analytical tools to ensure product quality, consistency, and regulatory compliance.

Rising technological advancements in bioprocess analyzers, including the integration of automation, miniaturization, and advanced sensor technologies, enhance their efficiency, accuracy, and reliability, driving their adoption across biopharmaceutical manufacturing facilities. These advanced analyzers enable real-time monitoring of critical process parameters, such as cell viability, metabolite concentrations, and product titers, facilitating process optimization and faster time-to-market for biopharmaceutical products.

The bioprocess analyzer industry is classified into product, analysis type, application, end use and region

Based on product, the market value from the instruments segment is expected to witness 15.4% CAGR through 2032. Rapid advancements in bioprocess technology and increasing demand for biopharmaceuticals are necessitating sophisticated analytical instruments capable of monitoring and optimizing complex bioprocessing workflows. Instruments, such as spectrophotometers, chromatography systems, and mass spectrometers, enable real-time analysis of critical process parameters for ensuring product quality, consistency, and regulatory compliance.

bioprocess analyzers market from the antibiotics application segment is slated to generate notable revenue at 15.4% CAGR during 2024-2032. The increasing prevalence of infectious diseases and antibiotic-resistant pathogens is driving the demand for novel antibiotics and antimicrobial agents, necessitating efficient bioprocesses for their production. To that end, bioprocess analyzers help in optimizing fermentation and purification processes while ensuring the quality, yield, and consistency of antibiotic production.

Asia Pacific bioprocess analyzers market size will record a 15.8% growth rate through 2032. The expanding biopharmaceutical sector, fueled by increasing demand for personalized medicine and biologics, is necessitating advanced analytical tools for process optimization and quality control in bioprocessing workflows. Rapid technological advancements in bioprocess analyzers, such as automation, miniaturization, and real-time monitoring capabilities to enhance their efficiency and accuracy will further drive the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing demand for biopharmaceutical products
    • 3.2.1.2 Advancements in biotechnology and bioprocessing
    • 3.2.1.3 Increasing demand for biosimilars
    • 3.2.1.4 Rising government initiatives and funding
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of instruments
    • 3.2.2.2 Complexity and technical expertise
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Instruments
• 5.3 Consumables & accessories

Chapter 6 Market Estimates and Forecast, By Analysis Type, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Substrate analysis
• 6.3 Metabolite analysis
• 6.4 Contentration detection

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Antibiotics
• 7.3 Recombinant proteins
• 7.4 Biosimilars
• 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Biopharmaceutical companies
• 8.3 CROs & CMOs
• 8.4 Research & academic institutes
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Agilent Technologies, Inc.
• 10.2 Algenax
• 10.3 Danaher Corporation
• 10.4 F. Hoffmann-La Roche Ltd.
• 10.5 Groton Biosystems LLC
• 10.6 Kaiser Optical Systems, Inc.
• 10.7 Nova Biomedical
• 10.8 Randox Laboratories Ltd.
• 10.9 Sartorius AG
• 10.10 SYSBIOTECH GmbH
• 10.11 Thermo Fisher Scientific Inc.
• 10.12 YSI Inc.